Filter
Period
Filter by
recent search
Showing: 1 – 05 of 152 Regulated Information
Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook
Paris (France), 13 February 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its financial results for the full year 2019.
–
28 May 2019
28 May 2019